Table 2.
Implantation and post‐implantation characteristics for recovery patients
| With follow‐up (28) | No follow‐up (17) | P‐value | |
|---|---|---|---|
| Device strategy | <0.001 | ||
| BTT | 22 (78.5%) | 7 (36.9%) | |
| DT | 2 (7.1%) | 2 (10.5%) | |
| Rescue therapy | 4 (14.3%) | 2 (10.5%) | |
| Bridge to recovery | 0 (0%) | 8 (42.1%) | |
| Device type | 0.204 | ||
| HeartMate II | 14 (50%) | 6 (31.6%) | |
| HVAD | 11 (39.3%) | 9 (47.4%) | |
| HeartMate 3 | 2 (7.1%) | 0 (0%) | |
| PVAD | 0 (0%) | 2 (10.5%) | |
| Other/unknown | 1 (3.6%) | 2 (10.5%) | |
| Concomitant cardiac procedures | |||
| PFO/ASD closure | 3 (10.7%) | 2 (10.5%) | |
| Tricuspid repair | 1 (3.6%) | 4 (21.1%) | |
| Tricuspid replacement | 1 (5.3%) | ||
| Aortic repair | 1 (5.3%) | ||
| Aortic valve replacement | 1 (3.6%) | ||
| Mitral repair | 1 (5.3%) | ||
| CABG | 1 (5.3%) | ||
| Concomitant temporary RVAD implantation | 2 (7.1%) | 2 (10.5%) | 1.000 |
| Time in OR (min) | 208 (130–683) | 276 (95–375) | 0.600 |
| Cardiopulmonary bypass time (min) | 75 (95–147) | 124 (50–235) | 0.034 |
| ICU stay (days) | 17 (4–147) | 27 (2–66) | 0.377 |
| Hospital stay (days) | 30 (17–165) | 39 (14–144) | 0.328 |
ASD, atrial septal defect; BTT, bridge to transplantation; CABG, coronary artery bypass grafting; DT, destination therapy; ICU, intensive care unit; OR, operating room; PFO, patent foramen ovale; RVAD, right ventricular assist device.
Values are median (range) or n (%).